Literature DB >> 1644314

Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics.

J Allignet1, V Loncle, N el Sohl.   

Abstract

The Staphylococcus aureus plasmid gene, vga, conferring resistance to A compounds of virginiamycin-like antibiotics (streptogramin A, pristinamycin II, virginiamycin M), and to synergistic mixtures of the A and B compounds of these antibiotics, was cloned and sequenced. This gene potentially encodes a 522-amino acid protein, VgA, of 60,115 Da which exhibits significant homology with the ATP-binding domains of numerous proteins. VgA has two ATP-binding domains, containing each the A and the B motifs, but does not contain long hydrophobic stretches that might represent potential membrane-spanning domains. Resistance to A compounds of virginiamycin-like antibiotics conferred to S. aureus by gene vga was not conferred to Escherichia coli, although a protein having an M(r) similar to that encoded by this gene was detected in E. coli minicells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644314     DOI: 10.1016/0378-1119(92)90488-b

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  49 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds.

Authors:  G Werner; W Witte
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds.

Authors:  J Haroche; J Allignet; C Buchrieser; N El Solh
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci.

Authors:  G Lina; A Quaglia; M E Reverdy; R Leclercq; F Vandenesch; J Etienne
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.

Authors:  Brigitte Malbruny; Annie Canu; Bülent Bozdogan; Bruno Fantin; Virginie Zarrouk; Sylvie Dutka-Malen; Celine Feger; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

6.  Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals.

Authors:  Julien Haroche; Anne Morvan; Marilyne Davi; Jeanine Allignet; François Bimet; Névine El Solh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe.

Authors:  M Soltani; D Beighton; J Philpott-Howard; N Woodford
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

8.  Screening of a Leptospira biflexa mutant library to identify genes involved in ethidium bromide tolerance.

Authors:  Helena Pětrošová; Mathieu Picardeau
Journal:  Appl Environ Microbiol       Date:  2014-07-25       Impact factor: 4.792

9.  Transcriptional termination control of a novel ABC transporter gene involved in antibiotic resistance in Bacillus subtilis.

Authors:  Reiko Ohki; Kozue Tateno; Teruaki Takizawa; Toshiko Aiso; Makiko Murata
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

10.  Tn5406, a new staphylococcal transposon conferring resistance to streptogramin a and related compounds including dalfopristin.

Authors:  Julien Haroche; Jeanine Allignet; Névine El Solh
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.